CPT Pharmacometrics & Systems PharmacologySystems BiologyPeer-reviewed journal article
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time Profiles
Felix JostiD, Clemens GiegerichiD, Christoph GrebneriD, Hans MatteriD, Henrik CordesiD
Abstract
Predicting pharmacokinetic (PK) profiles from molecular structures constitutes a significant advancement in pharmaceutical research with substantial implications for expediting the entire drug discovery process. Our investigation presents a comprehensive comparative analysis of five distinct methodological frameworks for predicting rat plasma concentration-time profiles: four approaches that integrate mechanistic modeling with computational techniques, and one approach employing pure machine learning (ML) architecture without physiological constraints. As reference (1), we used a method that predicts non-compartmental analysis (NCA) parameters to predict plasma PK profiles with a one-compartmental PK model (NCA-ML). Alternative approaches include: (2) a physiologically based PK (PBPK) model utilizing ML-predicted in vitro characteristics; (3) CMT-ML, where neural networks predict compartmental PK model parameters; (4) CMT-PINN, employing physics-informed neural networks; and (5) PURE-ML, using decision trees to predict concentration values at specific timepoints based on predicted volume of distribution and clearance. Assessment using multiple performance metrics demonstrated that the CMT-PINN approach achieved superior predictivity for PK profiles. Models trained directly on concentration-time, rather than derived PK parameters, delivered markedly improved predictive performance, particularly when working with limited training datasets. Our findings confirm the viability of predicting PK behavior from molecular structures before synthesis, representing a significant advancement for subsequent design. Implementation of these computational approaches enables informed compound selection early in the discovery pipeline, concentrating valuable resources for advanced preclinical investigations on only the most promising candidates, with anticipated beneficial effects on overall development timelines.
- organism: rat
- research focus: drug response / drug discovery
- approach: machine learning (classical)
- approach: experimental assay
- Citations
- 2
- FWCI
- 3.61
- Field percentile
- top 13%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In silico PK predictions in Drug Discovery: Benchmarking of Strategies to Integrate Machine Learning with Empiric and Mechanistic PK modelling
Moritz Walter, Ghaith Aljayyoussi, … Lina Humbeck·Clinical and Translational SciencePeer-reviewed·Mar 1, 2025
- A Combination of Machine Learning and PBPK Modeling Approach for Pharmacokinetics Prediction of Small Molecules in Humans
Y. Li, Z. Wang, … L. Lai·Pharmaceutical ResearchPeer-reviewed·Jun 25, 2024
- PKSmart: An Open-Source Computational Model to Predict in vivo Pharmacokinetics of Small Molecules
Srijit Seal, Maria‐Anna Trapotsi, … Andreas Bender·bioRxiv·Feb 2, 2024
- Hybrid Mechanistic-Neural Modeling of Concentration-Time Dynamics Generalizes Human Pharmacokinetics Prediction Across Unseen Chemical Space
Amitesh Badkul, Lianjin Cai, … Lei Xie·bioRxiv·Oct 8, 2026
- Towards pharmacokinetic profile predictions for monoclonal antibodies using sequence based machine learning derived parameters and compartmental modeling
Felix Jost, Henrik Cordes·bioRxiv·May 22, 2025
- KinasepKipred: A Predictive Model for Estimating Ligand-Kinase Inhibitor Constant (pKi).
Govinda KC, Md Mahmudulla Hassan, Suman Sirimulla·bioRxiv·Oct 31, 2019